Increased Long Noncoding RNA HCG18 Indicates the Adverse Prognosis and Deteriorating Development of Diffuse Large B Cell Lymphoma Through Suppressing miR‐494‐3p

Huanyu Guo; Yingjie Xie; Xiaorong Qin; Hongyan Li; Jianhua Hu; Huanyu Guo; Yingjie Xie; Xiaorong Qin; Hongyan Li; Jianhua Hu

doi:10.1155/ecc/8839021

2025 Volume 2025

Article Contents

Next Previous

RESEARCH ARTICLE Open Access

Increased Long Noncoding RNA HCG18 Indicates the Adverse Prognosis and Deteriorating Development of Diffuse Large B Cell Lymphoma Through Suppressing miR‐494‐3p

More Information

Published online: 22 June 2025
European Journal of Cancer Care 2025, Article number: 10.1155/ecc/8839021 (2025) | Cite this article

Rights and permissions
Copyright: © 2025 by the author(s). Exclusive Licensee Maximum Academic Press, Fayetteville, GA. This article is an open access article distributed under Creative Commons Attribution License (CC BY 4.0), visit https://creativecommons.org/licenses/by/4.0/.

About this article

Cite this article

Huanyu Guo, Yingjie Xie, Xiaorong Qin, Hongyan Li, Jianhua Hu. 2025. Increased Long Noncoding RNA HCG18 Indicates the Adverse Prognosis and Deteriorating Development of Diffuse Large B Cell Lymphoma Through Suppressing miR‐494‐3p. European Journal of Cancer Care. 2025:21 doi: 10.1155/ecc/8839021

Huanyu Guo, Yingjie Xie, Xiaorong Qin, Hongyan Li, Jianhua Hu. 2025. Increased Long Noncoding RNA HCG18 Indicates the Adverse Prognosis and Deteriorating Development of Diffuse Large B Cell Lymphoma Through Suppressing miR‐494‐3p. European Journal of Cancer Care. 2025:21 doi: 10.1155/ecc/8839021

Download PDF

Article Metrics

Article views(13) PDF downloads(12)